Takeshi Fujino¹, Susumu Goyama¹, Yuki Sugiura², Daichi Inoue³, Satoshi Yamasaki⁴, Akiko Matsumoto⁴, Naru Sato¹, Hironobu Morinaga⁵, Shiori Shikata¹, Reina Nagase¹, Tomofusa Fukuyama¹, Yosuke Tanaka¹, Shuhei Asada¹, Tsuyoshi Fukushima¹, Hiroaki Honda⁶, Emi Nishimura⁵, Tatsuhiro Shibata⁴, Omar Abdel-Wahab³, Makoto Suematsu², Toshio Kitamura¹ (1.Division of Cellular Therapy, University of Tokyo, Tokyo, Japan, 2.Department of Biochemistry, Keio University, Tokyo, Japan, 3.Memorial Sloan-Kettering Cancer Center, New York, USA, 4.Laboratory of Molecular Medicine, University of Tokyo, Tokyo, Japan, 5.Stem Cell Biology, Tokyo Medical and Dental University, Tokyo, Japan, 6.Human Disease Models, Tokyo Women^'s Medical University, Tokyo, Japan)

Yoshihiro Hayashi¹, Yuka Harada², Yuki Kagiyama¹, Ye Ding³, Jun Imagawa⁴, Naoki Shingai⁵, Naoko Kato⁶, Jiro Kitaura⁷, Norio Komatsu⁵, Hirotaka Matsui⁸, Issay Kitabayashi⁹, Atsushi Iwama¹⁰, Toshio Kitamura⁶, Hironori Harada¹ (1.Lab. Oncology, Tokyo University of Pharmacy & Life Sciences, Tokyo, Japan, 2.Dept. Clinical Laboratory Medicine, Bunkyo Gakuin University, Tokyo, Japan, 3.Div. Oncology and Hematology, Edogawa Hospital, Tokyo, Japan, 4.Dept. Hematology and Oncology, Hiroshima University, Hiroshima, Japan, 5.Dept. Hematology, Juntendo University, Tokyo, Japan, 6.Div. Cellular Therapy, IMS, the University of Tokyo, Tokyo, Japan, 7.Atopy Research Center, Juntendo University, Tokyo, Japan, 8.Dept. Molecular Laboratory Medicine, Kumamoto University, Kumamoto, Japan, 9.Div. Hematological Malignancy, National Cancer Center Research Institute, Tokyo, Japan, 10.Dept. Cellular and Molecular Medicine, Chiba University, Chiba, Japan)

Akiko Nagamachi¹, Hirotaka Matsui², Akinori Kanai³, Satoru Shinriki², Toshiya Inaba³ (1.Radiation Research Center, RIRBM, Hiroshima Univ., Japan, 2.Graduate School of Medical Sciences, Kumamoto Univ., Japan, 3.Division of Molecular Oncology, RIRBM, Hiroshima Univ., Japan)

Shiro Tara^1,2, Yaeko Nakajima-Takagi¹, Motohiko Oshima¹, Kazumasa Aoyama¹, Atsunori Saraya¹, Haruhiko Koseki³, Bardwell Vivian⁴, Atsushi Iwama⁵ (1.Cellular and Molecular Medicine, Chiba University, Chiba, Japan, 2.Hematology, Rheumatology and Infectious Diseases, Kumamoto University, Kumamoto, Japan, 3.Labolatory for Developmental Genetics, Yokohama, Japan, 4.Developmental Biology Center, Masonic Cancer Center, University of Minnesota, 5.Division of Stem Cell and Molecular Medicine, University of Tokyo)

Masahiro Nakagawa^1,2, Ryosaku Inagaki^1,2,3, Yasuhito Nannya¹, Lanying Zhao¹, June Takeda¹, Akinori Yoda¹, Ayana Kon¹, Tetsuichi Yoshizato¹, Hisashi Tsurumi⁴, Hideki Makishima¹, Seishi Ogawa¹ (1.Department of Pathology and Tumor Biology, Kyoto University, 2.DSK Project, Medical Innovation Center, Kyoto University, 3.Genomic Science Labolatories, Sumitomo Dainippon Pharma Co., Ltd., 4.Department of Hematology, Gifu University)

Suguru Morimoto¹, Hideki Makishima¹, Yasunobu Nagata¹, Constance Baer², Niroshan Nadarajah², Tamara Alpermann², Genta Nagae³, Yasuhito Nannya¹, Yasushi Miyazaki⁴, Kenichi Yoshida¹, Tetsuichi Yoshizato¹, Masahiro Nakagawa¹, Ryosaku Inagaki¹, June Takeda¹, Yoichi Fujii¹, Yasuhide Takeuchi¹, Yuichi Shiraishi⁵, Kenichi Chiba⁵, Hiroko Tanaka⁶, Masashi Sanada^1,7, Satoru Miyano^5,6, Claudia Haferlach², Wolfgang Kern², Hiroyuki Aburatani³, Torsten Haferlach², Seishi Ogawa¹ (1.Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan, 2.MLL Munich Leukemia Laboratory, Munich, Germany, 3.The University of Tokyo, Tokyo, Japan, 4.Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 5.Laboratory of Sequence Data Analysis, Human Genome Center, 6.Laboratory of DNA Information Analysis, Institute of Medical Science, 7.National Hospital Organization Nagoya Medical Center, Nagoya, Japan)